Korro Bio, Inc. Gain (Loss) on Disposition of Assets
Korro Bio, Inc. (KRRO) reported Gain (Loss) on Disposition of Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-06
- Korro Bio, Inc. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was $18.00K.
- Korro Bio, Inc. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was $0.00.
- Korro Bio, Inc. gain (loss) on disposition of assets for the quarter ending 2024-12-31 was -$357.00K.
- Korro Bio, Inc. gain (loss) on disposition of assets for the quarter ending 2024-09-30 was $0.00.
- Korro Bio, Inc. gain (loss) on disposition of assets for fiscal 2025 was -$63.00K.
- Korro Bio, Inc. gain (loss) on disposition of assets for fiscal 2024 was -$357.00K.
- Korro Bio, Inc. gain (loss) on disposition of assets for fiscal 2023 was -$65.00K.
- Korro Bio, Inc. gain (loss) on disposition of assets for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $18.00K derived: sum of 2 quarters · filed 2026-03-12 | -$63.00K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$81.00K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | -$81.00K 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | -$357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$357.00K derived: sum of 2 quarters · filed 2026-03-12 | -$357.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | -$65.00K 10-K · filed 2025-03-18 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $0.00 derived: sum of 2 quarters · filed 2024-03-26 | $0.00 10-K · filed 2024-03-26 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $0.00 derived: sum of 2 quarters · filed 2023-03-10 | -$16.00K 10-K · filed 2023-03-10 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$16.00K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | -$16.00K 10-Q · filed 2022-08-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |